Physician profile
Amanda King
NPI 1407210883
$1,311.68
in general payments reported to CMS, 2019-2025
25 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $76.19 · 2021: $83.04 · 2022: $331 · 2023: $376 · 2024: $272 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784 · Travel and Lodging: $37.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.24 |
| Travel and Lodging | $37.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $305.48 | 2020-2025 | |
| Astellas Pharma US INC | $131.80 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $113.86 | 2021-2024 | Acessa Provu System, Aptima |
| Mayne Pharma Commercial LLC | $106.10 | 2022-2024 | |
| Coopersurgical, INC. | $73.41 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $69.47 | 2021-2025 | Nexplanon, Jada System |
| Sage Therapeutics, LLC | $68.78 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $51.37 | 2022-2024 | |
| Amag Pharmaceuticals, INC. | $45.98 | 2021-2022 | |
| Agile Therapeutics, INC. | $44.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.34 | 2023-2024 | |
| Intuitive Surgical, INC. | $37.00 | 2025 | |
| Shield Therapeutics INC | $24.95 | 2024 | |
| Smith+Nephew, INC. | $20.60 | 2022 | |
| Merck Sharp & Dohme LLC | $19.79 | 2023 | Gardasil 9 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $19.33 | 2025 | Femlyv |
| Channel Medsystems, INC. | $17.40 | 2023 | |
| Novo Nordisk INC | $17.32 | 2025 | Wegovy |
| Evofem Biosciences, INC. | $17.14 | 2022 | |
| Daiichi Sankyo INC. | $16.82 | 2022 | |
| Mimedx Group, INC. | $16.54 | 2025 | |
| Therapeuticsmd, INC. | $15.49 | 2022 | |
| Avion Pharmaceuticals | $13.68 | 2020 | |
| Scynexis, INC. | $12.03 | 2022 | |
| Mylan Pharmaceuticals INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.